Poliomycetes Vaccine Market
1 Poliomycetes Vaccine Market Overview
1.1 Product Overview and Scope of Poliomycetes Vaccine
1.2 Poliomycetes Vaccine Segment by Type
1.2.1 Global Poliomycetes Vaccine Sales Growth Rate Comparison by Type (2023-2029)
1.2.2 Type 1
1.2.3 Type 2
1.3 Poliomycetes Vaccine Segment by Application
1.3.1 Global Poliomycetes Vaccine Sales Comparison by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Poliomycetes Vaccine Market Size Estimates and Forecasts
1.4.1 Global Poliomycetes Vaccine Revenue 2018-2029
1.4.2 Global Poliomycetes Vaccine Sales 2018-2029
1.4.3 Poliomycetes Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
2 Poliomycetes Vaccine Market Competition by Manufacturers
2.1 Global Poliomycetes Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Poliomycetes Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Poliomycetes Vaccine Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Poliomycetes Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Poliomycetes Vaccine Market Competitive Situation and Trends
2.5.1 Poliomycetes Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Poliomycetes Vaccine Players Market Share by Revenue
2.5.3 Global Poliomycetes Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Poliomycetes Vaccine Retrospective Market Scenario by Region
3.1 Global Poliomycetes Vaccine Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Poliomycetes Vaccine Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Poliomycetes Vaccine Market Facts & Figures by Country
3.3.1 North America Poliomycetes Vaccine Sales by Country
3.3.2 North America Poliomycetes Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Poliomycetes Vaccine Market Facts & Figures by Country
3.4.1 Europe Poliomycetes Vaccine Sales by Country
3.4.2 Europe Poliomycetes Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Poliomycetes Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Poliomycetes Vaccine Sales by Region
3.5.2 Asia Pacific Poliomycetes Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Poliomycetes Vaccine Market Facts & Figures by Country
3.6.1 Latin America Poliomycetes Vaccine Sales by Country
3.6.2 Latin America Poliomycetes Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Poliomycetes Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Poliomycetes Vaccine Sales by Country
3.7.2 Middle East and Africa Poliomycetes Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Poliomycetes Vaccine Historic Market Analysis by Type
4.1 Global Poliomycetes Vaccine Sales Market Share by Type (2018-2023)
4.2 Global Poliomycetes Vaccine Revenue Market Share by Type (2018-2023)
4.3 Global Poliomycetes Vaccine Price by Type (2018-2023)
5 Global Poliomycetes Vaccine Historic Market Analysis by Application
5.1 Global Poliomycetes Vaccine Sales Market Share by Application (2018-2023)
5.2 Global Poliomycetes Vaccine Revenue Market Share by Application (2018-2023)
5.3 Global Poliomycetes Vaccine Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Sanofi S.A
6.1.1 Sanofi S.A Corporation Information
6.1.2 Sanofi S.A Description and Business Overview
6.1.3 Sanofi S.A Poliomycetes Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi S.A Poliomycetes Vaccine Product Portfolio
6.1.5 Sanofi S.A Recent Developments/Updates
6.2 United Pharma Industries Co Ltd
6.2.1 United Pharma Industries Co Ltd Corporation Information
6.2.2 United Pharma Industries Co Ltd Description and Business Overview
6.2.3 United Pharma Industries Co Ltd Poliomycetes Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 United Pharma Industries Co Ltd Poliomycetes Vaccine Product Portfolio
6.2.5 United Pharma Industries Co Ltd Recent Developments/Updates
6.3 Gansu Conbest Biotech Co., Ltd.
6.3.1 Gansu Conbest Biotech Co., Ltd. Corporation Information
6.3.2 Gansu Conbest Biotech Co., Ltd. Description and Business Overview
6.3.3 Gansu Conbest Biotech Co., Ltd. Poliomycetes Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Gansu Conbest Biotech Co., Ltd. Poliomycetes Vaccine Product Portfolio
6.3.5 Gansu Conbest Biotech Co., Ltd. Recent Developments/Updates
6.4 Shenzhen Mellow Hope Pharm Industrial Co., Ltd.
6.4.1 Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Corporation Information
6.4.2 Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Description and Business Overview
6.4.3 Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Poliomycetes Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Poliomycetes Vaccine Product Portfolio
6.4.5 Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Recent Developments/Updates
6.5 China National Biotec Group
6.5.1 China National Biotec Group Corporation Information
6.5.2 China National Biotec Group Description and Business Overview
6.5.3 China National Biotec Group Poliomycetes Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 China National Biotec Group Poliomycetes Vaccine Product Portfolio
6.5.5 China National Biotec Group Recent Developments/Updates
6.6 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Poliomycetes Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Serum Institute of India Poliomycetes Vaccine Product Portfolio
6.6.5 Serum Institute of India Recent Developments/Updates
7 Poliomycetes Vaccine Manufacturing Cost Analysis
7.1 Poliomycetes Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Poliomycetes Vaccine
7.4 Poliomycetes Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Poliomycetes Vaccine Distributors List
8.3 Poliomycetes Vaccine Customers
9 Poliomycetes Vaccine Market Dynamics
9.1 Poliomycetes Vaccine Industry Trends
9.2 Poliomycetes Vaccine Market Drivers
9.3 Poliomycetes Vaccine Market Challenges
9.4 Poliomycetes Vaccine Market Restraints
10 Global Market Forecast
10.1 Poliomycetes Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Poliomycetes Vaccine by Type (2024-2029)
10.1.2 Global Forecasted Revenue of Poliomycetes Vaccine by Type (2024-2029)
10.2 Poliomycetes Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Poliomycetes Vaccine by Application (2024-2029)
10.2.2 Global Forecasted Revenue of Poliomycetes Vaccine by Application (2024-2029)
10.3 Poliomycetes Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Poliomycetes Vaccine by Region (2024-2029)
10.3.2 Global Forecasted Revenue of Poliomycetes Vaccine by Region (2024-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Poliomycetes Vaccine Sales Growth Rate Comparison by Type (2023-2029) & (K Doses) & (US$ Million)
Table 2. Global Poliomycetes Vaccine Sales Growth Rate Comparison by Application (2023-2029) & (K Doses) & (US$ Million)
Table 3. Global Poliomycetes Vaccine Market Size by Region (US$ Million) (2018 VS 2022 VS 2029)
Table 4. Global Poliomycetes Vaccine Market Competitive Situation by Manufacturers in 2022
Table 5. Global Poliomycetes Vaccine Sales (K Doses) of Key Manufacturers (2018-2023)
Table 6. Global Poliomycetes Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Poliomycetes Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global Poliomycetes Vaccine Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market Poliomycetes Vaccine Average Price (USD/Dose) of Key Manufacturers (2018-2023)
Table 10. Manufacturers Poliomycetes Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Poliomycetes Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Poliomycetes Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Poliomycetes Vaccine as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Poliomycetes Vaccine Sales by Region (2018-2023) & (K Doses)
Table 16. Global Poliomycetes Vaccine Sales Market Share by Region (2018-2023)
Table 17. Global Poliomycetes Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global Poliomycetes Vaccine Revenue Market Share by Region (2018-2023)
Table 19. North America Poliomycetes Vaccine Sales by Country (2018-2023) & (K Doses)
Table 20. North America Poliomycetes Vaccine Sales Market Share by Country (2018-2023)
Table 21. North America Poliomycetes Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America Poliomycetes Vaccine Revenue Market Share by Country (2018-2023)
Table 23. Europe Poliomycetes Vaccine Sales by Country (2018-2023) & (K Doses)
Table 24. Europe Poliomycetes Vaccine Sales Market Share by Country (2018-2023)
Table 25. Europe Poliomycetes Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe Poliomycetes Vaccine Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific Poliomycetes Vaccine Sales by Region (2018-2023) & (K Doses)
Table 28. Asia Pacific Poliomycetes Vaccine Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific Poliomycetes Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific Poliomycetes Vaccine Revenue Market Share by Region (2018-2023)
Table 31. Latin America Poliomycetes Vaccine Sales by Country (2018-2023) & (K Doses)
Table 32. Latin America Poliomycetes Vaccine Sales Market Share by Country (2018-2023)
Table 33. Latin America Poliomycetes Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America Poliomycetes Vaccine Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa Poliomycetes Vaccine Sales by Country (2018-2023) & (K Doses)
Table 36. Middle East and Africa Poliomycetes Vaccine Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa Poliomycetes Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa Poliomycetes Vaccine Revenue Market Share by Country (2018-2023)
Table 39. Global Poliomycetes Vaccine Sales by Type (2018-2023) & (K Doses)
Table 40. Global Poliomycetes Vaccine Sales Market Share by Type (2018-2023)
Table 41. Global Poliomycetes Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global Poliomycetes Vaccine Revenue Share by Type (2018-2023)
Table 43. Global Poliomycetes Vaccine Price by Type (2018-2023) & (USD/Dose)
Table 44. Global Poliomycetes Vaccine Sales (K Doses) by Application (2018-2023)
Table 45. Global Poliomycetes Vaccine Sales Market Share by Application (2018-2023)
Table 46. Global Poliomycetes Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Poliomycetes Vaccine Revenue Share by Application (2018-2023)
Table 48. Global Poliomycetes Vaccine Price by Application (2018-2023) & (USD/Dose)
Table 49. Sanofi S.A Corporation Information
Table 50. Sanofi S.A Description and Business Overview
Table 51. Sanofi S.A Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 52. Sanofi S.A Poliomycetes Vaccine Product
Table 53. Sanofi S.A Recent Developments/Updates
Table 54. United Pharma Industries Co Ltd Corporation Information
Table 55. United Pharma Industries Co Ltd Description and Business Overview
Table 56. United Pharma Industries Co Ltd Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 57. United Pharma Industries Co Ltd Poliomycetes Vaccine Product
Table 58. United Pharma Industries Co Ltd Recent Developments/Updates
Table 59. Gansu Conbest Biotech Co., Ltd. Corporation Information
Table 60. Gansu Conbest Biotech Co., Ltd. Description and Business Overview
Table 61. Gansu Conbest Biotech Co., Ltd. Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 62. Gansu Conbest Biotech Co., Ltd. Poliomycetes Vaccine Product
Table 63. Gansu Conbest Biotech Co., Ltd. Recent Developments/Updates
Table 64. Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Corporation Information
Table 65. Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Description and Business Overview
Table 66. Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 67. Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Poliomycetes Vaccine Product
Table 68. Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Recent Developments/Updates
Table 69. China National Biotec Group Corporation Information
Table 70. China National Biotec Group Description and Business Overview
Table 71. China National Biotec Group Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 72. China National Biotec Group Poliomycetes Vaccine Product
Table 73. China National Biotec Group Recent Developments/Updates
Table 74. Serum Institute of India Corporation Information
Table 75. Serum Institute of India Description and Business Overview
Table 76. Serum Institute of India Poliomycetes Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 77. Serum Institute of India Poliomycetes Vaccine Product
Table 78. Serum Institute of India Recent Developments/Updates
Table 79. Production Base and Market Concentration Rate of Raw Material
Table 80. Key Suppliers of Raw Materials
Table 81. Poliomycetes Vaccine Distributors List
Table 82. Poliomycetes Vaccine Customers List
Table 83. Poliomycetes Vaccine Market Trends
Table 84. Poliomycetes Vaccine Market Drivers
Table 85. Poliomycetes Vaccine Market Challenges
Table 86. Poliomycetes Vaccine Market Restraints
Table 87. Global Poliomycetes Vaccine Sales Forecast by Type (2024-2029) & (K Doses)
Table 88. Global Poliomycetes Vaccine Sales Market Share Forecast by Type (2024-2029)
Table 89. Global Poliomycetes Vaccine Revenue Forecast by Type (2024-2029) & (US$ Million)
Table 90. Global Poliomycetes Vaccine Revenue Market Share Forecast by Type (2024-2029)
Table 91. Global Poliomycetes Vaccine Sales Forecast by Application (2024-2029) & (K Doses)
Table 92. Global Poliomycetes Vaccine Sales Market Share Forecast by Application (2024-2029)
Table 93. Global Poliomycetes Vaccine Revenue Forecast by Application (2024-2029) & (US$ Million)
Table 94. Global Poliomycetes Vaccine Revenue Market Share Forecast by Application (2024-2029)
Table 95. Global Poliomycetes Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 96. Global Poliomycetes Vaccine Sales Market Share Forecast by Region (2024-2029)
Table 97. Global Poliomycetes Vaccine Revenue Forecast by Region (2024-2029) & (US$ Million)
Table 98. Global Poliomycetes Vaccine Revenue Market Share Forecast by Region (2024-2029)
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Poliomycetes Vaccine
Figure 2. Global Poliomycetes Vaccine Market Share by Type in 2022 & 2029
Figure 3. Type 1 Product Picture
Figure 4. Type 2 Product Picture
Figure 5. Global Poliomycetes Vaccine Market Share by Application in 2022 & 2029
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Global Poliomycetes Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 10. Global Poliomycetes Vaccine Market Size (2018-2029) & (US$ Million)
Figure 11. Global Poliomycetes Vaccine Sales (2018-2029) & (K Doses)
Figure 12. Poliomycetes Vaccine Sales Share by Manufacturers in 2022
Figure 13. Global Poliomycetes Vaccine Revenue Share by Manufacturers in 2022
Figure 14. The Global 5 and 10 Largest Poliomycetes Vaccine Players: Market Share by Revenue in 2022
Figure 15. Poliomycetes Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 16. Global Poliomycetes Vaccine Sales Market Share by Region (2018-2023)
Figure 17. Global Poliomycetes Vaccine Sales Market Share by Region in 2022
Figure 18. Global Poliomycetes Vaccine Revenue Market Share by Region (2018-2023)
Figure 19. Global Poliomycetes Vaccine Revenue Market Share by Region in 2022
Figure 20. U.S. Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 21. Canada Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 22. Germany Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 23. France Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 24. U.K. Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 25. Italy Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 26. Russia Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. China Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. Japan Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. South Korea Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. India Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. Australia Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. Taiwan Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. Indonesia Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. Thailand Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. Malaysia Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. Philippines Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Vietnam Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Mexico Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Brazil Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Argentina Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Turkey Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Saudi Arabia Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. U.A.E Poliomycetes Vaccine Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. Sales Market Share of Poliomycetes Vaccine by Type (2018-2023)
Figure 45. Manufacturing Cost Structure of Poliomycetes Vaccine
Figure 46. Manufacturing Process Analysis of Poliomycetes Vaccine
Figure 47. Poliomycetes Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Industry Market Size
